به نام خدا 1 Delayed puberty Mehdi salek MD Delayed puberty Initial physical changes of puberty are not present by age 13 years in girls 14 years in boys Delayed puberty lack of appropriate progression of puberty more than 4.5-5 years A boy who has’nt completed secondary sexual development within 4.5 years A girl who does’nt menstruate within 5 years Classification of Delayed Puberty Gonadotropin deficiency CNS tumors Functional HH Infiltrative Trauma Isolated Gonadotropin Genetic forms CDP Hypergonadotropic Hypogonadism Classification of Delayed Puberty Non-pathologic pathologic Classification of Delayed Puberty Transient Permanent Evaluation Evaluation History Infertility Anosmia → HH Cryptorchidism → HH Small penis in neonate → HH low Gn in neonatal period → HH Evaluation Family pattern attainment of menarche Family history of delay pubertal Constitutional delay often have a positive family Birth trauma Familial marriage Evaluation Chemotherapy Glucocorticoid therapy Surgery History of intense exercise Exposures to irradiation Growth chart Growth pattern Late onset growth failure CNS mass lesion Organic disease Occasionally MRI IS necessary Growth chart Normal growth velocity for BA → CDGP Normal growth pattern without growth spurt With anosmia Kallmann syndrom Without anosmia ↓isolated gonadotropin Physical Examination Neurologic examination Gynecomastia midline facial malformations Size of glandular breast tissue ,areolarsize Testing of sense of smell Galactorrhea Turner stigma Retractile testes Physical Examinatin Height especially HT velocity at least 6 12 months upper to lower segment ratio ↑↑U/L → CDG ↓↓U/L → Hypogonadism Physical Examinatin Signs of puberty Testicular location ,size, and consistency Prepubertal: Normal size testis <2.0 cc or longer<1.5 cm Early puberty: Normal size testis >3.0 cc or longer >2.5 cm pubertal-aged A testis ≤1.0cm particularly if unusually firm or soft suggestive of a hypogonadal state. initial Approach Skeletal age Gonadotropin status initial Approach BA = 11-13 years Gonadotropin measurement High Primary gonadal failure Girl Boy Turner Klinefelter initial Approach Mild Elevated→ GnRH Test Exaggerated response Primary gonadal failure initial Approach Low or lower limit of normal level Constitutional Delay Chronic disease permanent Gonadotropin initial Approach Low gonadotropin levels and pubertal delay may result from a physiologic delay or a permanent defect General Approach Diagnosis of HH versus CDP is more difficult because of Overlap in physical and laboratory finding General Approach Hypogona Hypogo FSH and LH are low They haven't a pulsatile LH with↑ bone age General Approach Overlap between HH and an immature hypothalamus if BA<10–11 years for girls BA<12–13 for boys General Approach In older adolescent Minimal response to GnRH Test suggests Gonadotropin Deficiency Pubertal rise in the child with delayed puberty suggests CDP General Approach Patients with HH have normal height in early or mid adolescent Patients with CDP have a normal growth rate for BA but are short for CA. Laboratory assessment CBC Electrolytes LFT ESR Prolactin Cortisol IGF-1 TSH, Free T4 Sex steroids ,DHEAS FSH, LH MIH,INSL3,PSA Laboratory assessment Karyotype Bone age Brain imaging for HH or hyperprolactinemia pelvic ultrasound urinary pH,SG urea nitrogen, creatinine Treatment Management Girls low dose estrogen therapy started at 13 years or bone age >11 years Continue 3- to 4-month in CDP Management 0.3mg of conjugated estrogens every other day 5ug of ethinyl estradiol daily 0.025 mg transdermal estrogen twice weekly Management If permanent HH Estrogen can be increased every 6 to 12 months in order to reach full replacement doses after two to three years of therapy Management During 2-3 years Daily doses of 0.6 - 1.25mg of conjugated estrogen or 10 -20ug ethinylestradiol are accepted as full replacement doses Cyclical progesterone 5 to 10mg of daily for 12 days can be added every month to induce monthly menstrual bleeding Management Boys The initial dosage should be low to avoid priapism and rapid pubertal development Dose should be adjusted based on intellectual maturation, and psychological needs Response, age, social Treatment If skeletal age is immature Risk of accelerating BA, short adult height If it is started at pubertal bone age 12-13 No detrimental effect on adult height leads to somatic and genital growth Treatment In boys of age 14 Testosterone Dose 50 to 100mg IM every four weeks Three to six months Oxandrolone 2.5mg/day Management After a few months Treatment should be stopped for Differentiation temporary from permanent Then Testosterone level to determine for endogenous androgen production. Management Testosterone <50 ng/dl Give another course After a few months Treatment should be stopped for Differentiation temporary from permanent Given 1-2 course Management If testosterone remain low→ Gona Continue treatment with androgen Dosages gradually increase to full replacement after three to four years 100 mg/wk, 200 mg/ two wk or 300mg three week intervals Management The skin gel preparation 50, 75, or 100 mg Absorption over a 24-hours Recommended sites are the shoulders, upper arms and abdomen Management Testosterone >50 ng/dl →CDP Treatment should be stop To assess progression of puberty Hypothalamic-pituitary-testicular function can be assumed if Testosterone > 275 ng/dl Testicular examination is normal Management Bone age 12 to 13 years in girls 13 or 14 years in boys patients with CDP usually continue pubertal development patients with gonadotropin deficiency do not progress and may regress. Management when fertility is desired Biosynthetic LH and FSH administration is utilized Episodic administration of LHRH Portable pumps to administer LHRH in episodic fashion over prolonged periods Case History 15yr old boy Shortest in his class No problem at school Always a small boy No chronic disease Father didn’t grow till he entered college Case physical No dysmorphic features CVS, Resp, Abd Exam normal Normal development Ht= 135cm Wt= 30kg U/l = near one Testicular volume =2.5ml Case physical Testicular length = 1.5cm Penis = 4cm Normal Testicular consistency No gynecomastia Arm span – height span= 2cm GV =5cm/yr PH=1 Hormonal and biochemical studies Normal BUN /ESR Normal T4 &TSH Low IGF1& IGFBP3 for age Normal IGF1& IGFBP3 for BA Decreased FSH& LH Hormonal and biochemical studies Testosterone= 0/15ng / ml Celiac test= ok Cortisol levels = ok LHRH shows not yet in puberty Normal prolactin Case treatment Oxandrolon for 6 month Zinc 12.5 mg/day Iron 12mg/day for 3 mo Vitamin A = 6000IU/week for 3 mo But Testicular volume &Testicular length Didn’t change Case imaging BA=12yr Diagnosis? Any treatment ? Case treatment Testosteron 1mg/kg for 4 month Letrozol 2.5mg Case treatment Six month after stopping of Testosteron Testosteron level was 0/8ng/ml Testicular volume =5ml Testicular length = 3cm Discussion Constitutional Delay Puberty Multifactorial Fathers has similar pattern often in boys Normal size at birth . . . . - Constitutional Delay Puberty By three years of age Decrease height ,BA, growth velocity By usual age of puberty immaturity become more noticeable as the approaches with somatic and sexual pubertal At older age than typical Puberty occurring spontaneously Constitutional Delay Puberty 61 No history of systemic illness. Normal nutrition. Normal P/E. Normal hormones Constitutional Delay Puberty 62 Delayed puberty. Delayed bone age. a short adolescent with bone age delay greater than three years is more likely to have a pathologic problem . Constitutional Delay Puberty Growth velocity and height are usually appropriate for bone age Delay in the reactivation of the GnRH pulse generator Adrenarche and gonadarche occur later Constitutional Delay Puberty Outcome is benign Normal physical development, sexual and reproductive function Constitutional Delay Puberty Not one test yet distinguishes between CDP and HH, so watchful waiting is usually in order Constitutional Delay Puberty Hypogonadotropin hypogonadism Adrenarche at a normal age Higher DHEAS than CDG Failure of a rise in Gonadotropin or sex steroid by age 18 Treatment Assurance to family GH treatment Treatment for BA>12y Don’t Treatment for BA<10y or CA<12 Oxandrolon Transdermal patch and gel preparations of testosterone